Polo-like kinases mediate cell survival in mitochondrial dysfunction

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 34, 2009, Pages 14542-14546

  Matsumoto, Takumi ^a   Wang, Ping Yuan ^a   Ma, Wenzhe ^a   Ho, Joong Sung ^a   Matoba, Satoaki ^b   Hwang, Paul M ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Cell cycle; Respiration; sco2

Indexed keywords

POLO LIKE KINASE 1; POLO LIKE KINASE 2;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL CYCLE; CELL FUNCTION; CELL GROWTH; CELL SURVIVAL; COLONY FORMATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LENTIVIRINAE; MICROARRAY ANALYSIS; MITOCHONDRIAL RESPIRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; XENOGRAFT;

ANIMALS; APOPTOSIS; CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; CELL SURVIVAL; ELECTRON TRANSPORT; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; IMMUNOBLOTTING; MICE; MICE, NUDE; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; NEOPLASMS, EXPERIMENTAL; OXYGEN CONSUMPTION; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SERINE; SIGNAL TRANSDUCTION; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 70149113965     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0904229106     Document Type: Article

References (36)

1. Kim JW, Dang CV (2006) Cancer's molecular sweet tooth and the Warburg effect. Cancer Res 66:8927-8930.
2. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB (2008) The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7:11-20.
3. Warburg O (1956) On the origin of cancer cells. Science 123:309-314.
4. Kastan MB, Bartek J (2004) Cell-cycle checkpoints and cancer. Nature 432:316-323.
5. Schieke SM, Finkel T (2006) Mitochondrial signaling, TOR, and life span. Biol Chem 387:1357-1361.
6. Papadopoulou LC, et al. (1999) Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nat Genet 23:333-337.
7. Eckerdt F, Yuan J, Strebhardt K (2005) Polo-like kinases and oncogenesis. Oncogene 24:267-276.
8. van de Weerdt BC, Medema RH (2006) Polo-like kinases: A team in control of the division. Cell Cycle 5:853-864.
9. Liu X, Lei M, Erikson RL (2006) Normal cells, but not cancer cells, survive severe Plk1 depletion. Mol Cell Biol 26:2093-2108. (Pubitemid 43346913)
10. Hirata R, Chamberlain J, Dong R, Russell DW (2002) Targeted transgene insertion into human chromosomes by adeno-associated virus vectors. Nat Biotechnol 20:735-738. (Pubitemid 34734142)
11. Kohli M, Rago C, Lengauer C, Kinzler KW, Vogelstein B (2004) Facile methods for generating human somatic cell gene knockouts using recombinant adeno-associated viruses. Nucleic Acids Res 32:e3.
12. Topaloglu O, Hurley PJ, Yildirim O, Civin CI, Bunz F (2005) Improved methods for the generation of human gene knockout and knockin cell lines. Nucleic Acids Res 33:e158. (Pubitemid 41742634)
13. Rago C, Vogelstein B, Bunz F (2007) Genetic knockouts and knockins in human somatic cells. Nat Protoc 2:2734-2746.
14. Matoba S, et al. (2006) p53 regulates mitochondrial respiration. Science 312:1650-1653.
15. Matthew EM, et al. (2007) Replication stress, defective S-phase checkpoint and increased death in Plk2-deficient human cancer cells. Cell Cycle 6:2571-2578.
16. Pak DT, ShengM(2003) Targeted protein degradation and synapse remodeling by an inducible protein kinase. Science 302:1368-1373.
17. Butow RA, AvadhaniNG(2004) Mitochondrial signaling: The retrograde response. Mol Cell 14:1-15.
18. Walsh C, Barrow S, Voronina S, Chvanov M, Petersen OH, Tepikin A (2009) Modulation of calcium signalling by mitochondria. Biochim Biophys Acta Jan 21 [Epub ahead of print].
19. Jang YJ, Ma S, Terada Y, Erikson RL (2002) Phosphorylation of threonine 210 and the role of serine 137 in the regulation of mammalian polo-like kinase. J Biol Chem 277:44115-44120. (Pubitemid 36157840)
20. van de Weerdt BC, et al. (2005) Uncoupling anaphase-promoting complex/cyclosome activity from spindle assembly checkpoint control by deregulating polo-like kinase 1. Mol Cell Biol 25:2031-2044.
21. Ma S, Charron J, Erikson RL (2003) Role of Plk2 (Snk) in mouse development and cell proliferation. Mol Cell Biol 23:6936-6943. (Pubitemid 37214661)
22. Burns TF, Fei P, Scata KA, Dicker DT, El-DeiryWS(2003) Silencing of the novel p53 target gene Snk/Plk2 leads to mitotic catastrophe in paclitaxel (taxol)-exposed cells. Mol Cell Biol 23:5556-5571.
23. Smith P, Syed N, Crook T (2006) Epigenetic inactivation implies a tumor suppressor function in hematologic malignancies for Polo-like kinase 2 but not Polo-like kinase 3. Cell Cycle 5:1262-1264. (Pubitemid 43894276)
24. Scaffidi P, Misteli T, BianchiME(2002) Release of chromatin proteinHMGB1by necrotic cells triggers inflammation. Nature 418:191-195.
25. Toyoshima-Morimoto F, Taniguchi E, Nishida E (2002) Plk1 promotes nuclear translocation of human Cdc25C during prophase. EMBO Rep 3:341-348. (Pubitemid 34467604)
26. Seki A, Coppinger JA, Jang CY, Yates JR, Fang G (2008) Bora and the kinase Aurora a cooperatively activate the kinase Plk1 and control mitotic entry. Science 320:1655-1658. (Pubitemid 351931258)
27. Macurek L, et al. (2008) Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery. Nature 455:119-123.
28. Park JE, et al. (2009) Direct quantification of polo-like kinase 1 activity in cells and tissues using a highly sensitive and specific ELISA assay. Proc Natl Acad Sci USA 106:1725-1730.
29. Shimizu-Yoshida Y, et al. (2001) Radiation-inducible hSNK gene is transcriptionally regulated by p53 binding homology element in human thyroid cells. Biochem Biophys Res Commun 289:491-498. (Pubitemid 33141081)
30. Riley T, Sontag E, Chen P, Levine A (2008) Transcriptional control of human p53- regulated genes. Nat Rev Mol Cell Biol 9:402-412. (Pubitemid 351574202)
31. Syed N, et al. (2006) Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies. Blood 107:250-256. (Pubitemid 43053549)
32. Tan LB, Chen KT, Yuan YC, Liao PC, Guo HR (2009) Identification of urine PLK2 as a marker of bladder tumors by proteomic analysis. World J Urol Jun 9 [Epub ahead of print].
33. Sur S, et al. (2009) A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53. Proc Natl Acad Sci USA 106:3964-3969.
34. Inglis KJ, et al. (2009) Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system. J Biol Chem 284:2598-2602.
35. Patino WD, et al. (2005) Circulating transcriptome reveals markers of atherosclerosis. Proc Natl Acad Sci USA 102:3423-3428. (Pubitemid 40328061)
36. Al-Ejeh F, Darby JM, Brown MP (2009) Chemotherapy synergizes with radioimmunotherapy targeting La autoantigen in tumors. PLoS ONE 4:e4630.